Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).

MLA

Vrijmoeth, Hedwig D., et al. “Prevalence and Determinants of Persistent Symptoms after Treatment for Lyme Borreliosis: Study Protocol for an Observational, Prospective Cohort Study (LymeProspect).” BMC Infectious Diseases, vol. 19, no. 1, Apr. 2019, p. 324. EBSCOhost, https://doi.org/10.1186/s12879-019-3949-8.

APA

Vrijmoeth, H. D., Ursinus, J., Harms, M. G., Zomer, T. P., Gauw, S. A., Tulen, A. D., Kremer, K., Sprong, H., Knoop, H., Vermeeren, Y. M., van Kooten, B., Joosten, L. A. B., Kullberg, B.-J., Hovius, J. W. R., & van den Wijngaard, C. C. (2019). Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect). BMC Infectious Diseases, 19(1), 324. https://doi.org/10.1186/s12879-019-3949-8

Chicago

Vrijmoeth, Hedwig D, Jeanine Ursinus, Margriet G Harms, Tizza P Zomer, Stefanie A Gauw, Anna D Tulen, Kristin Kremer, et al. 2019. “Prevalence and Determinants of Persistent Symptoms after Treatment for Lyme Borreliosis: Study Protocol for an Observational, Prospective Cohort Study (LymeProspect).” BMC Infectious Diseases 19 (1): 324. doi:10.1186/s12879-019-3949-8.